Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-120 in Symptomatic GERD on PPI
NCT00587275Phase 2Terminated
- Sponsor
- Ocera Therapeutics
- Start
- Oct 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of activated charcoal in gastroesophageal reflux disease (GERD), sponsored by Ocera Therapeutics. Started Oct 2007; status: terminated.
02
Drugs
activated charcoal
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00587275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00587275.